[1]丁红萍,季晓燕,黄江,等.血清几丁质酶1、鸢尾素表达与不同类型糖尿病视网膜病变患者微血管损伤的相关性[J].眼科新进展,2021,41(7):664-667.[doi:10.13389/j.cnki.rao.2021.0137]
　DING Hongping,JI Xiaoyan,HUANG Jiang,et al.Correlation between the expression of serum chitotriosidase and Irisin and microvascular injury in patients with different types of diabetic retinopathy[J].Recent Advances in Ophthalmology,2021,41(7):664-667.[doi:10.13389/j.cnki.rao.2021.0137]
点击复制

血清几丁质酶1、鸢尾素表达与不同类型糖尿病视网膜病变患者微血管损伤的相关性/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年7期
页码:
664-667
栏目:
应用研究
出版日期:
2021-07-05

文章信息/Info

Title:
Correlation between the expression of serum chitotriosidase and Irisin and microvascular injury in patients with different types of diabetic retinopathy
作者:
丁红萍; 季晓燕; 黄江; 陈之阳
215000　江苏省苏州市，苏州大学附属第二医院眼科
Author(s):
DING Hongping; JI Xiaoyan; HUANG Jiang; CHEN Zhiyang
Department of Ophthalmology,the Second Affiliated Hospital of Soochow University, Suzhou 215000,Jiangsu Province,China
关键词:
糖尿病视网膜病变; 几丁质酶1; 鸢尾素; 微血管损伤
Keywords:
diabetic retinopathy;  chitinase-1;  Irisin;  microvascular injury
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2021.0137
文献标志码:
A
摘要:
目的　研究血清几丁质酶1(CHIT1)、鸢尾素(Irisin)的表达与不同类型糖尿病视网膜病变(DR)患者微血管损伤的相关性。方法　选取我院2018年6月至2020年6月收治的106例糖尿病患者，根据不同疾病类型分为A组（增生型DR）、B组（非增生型DR）、C组（无视网膜病变）。检测各组患者血清CHIT1、Irisin水平以及外周血循环内皮细胞(CEC)、内皮祖细胞(EPC)、循环祖细胞(CPC) 比例并进行比较，采用Pearson相关性分析DR患者血清CHIT1、Irisin的水平与CEC、EPC、CPC比例的相关性。Logistic回归分析影响增生型DR发生的危险因素。结果　A组、B组、C组患者血清CHIT1、Irisin水平以及外周血CEC、EPC、CPC比例差异均有统计学意义（均为P<0.001），其中A组患者血清CHIT1水平、CEC比例均明显高于B组、C组，而血清Irisin水平、EPC和CPC比例明显均低于B组、C组，差异均有统计学意义（均为P<0.05）。Pearson相关性分析结果显示，DR患者血清CHIT1水平与CEC比例均呈正相关，与EPC和CPC比例均呈负相关，而DR患者血清Irisin水平与CEC比例均呈负相关，与EPC和CPC比例均呈正相关（均为P<0.001）。增生型DR患者的糖尿病病程、血清CHIT1水平、尿微量白蛋白均明显高于其他患者，增生型DR患者的血清Irisin水平均明显低于其他患者，差异均有统计学意义（均为P<0.05）。Logistic回归分析显示，糖尿病病程、CHIT1水平、Irisin水平、尿微量白蛋白均是糖尿病患者发生增生型DR的影响因素（均为P<0.05）。结论　DR患者血清CHIT1、Irisin异常表达，且与微血管损伤密切关联，是DR进展至增生型DR的影响因素。
Abstract:
Objective　To study the correlation between the expression of serum chitotriosidase (CHIT1) and irisin (Irisin) and microvascular damage in patients with different types of diabetic retinopathy (DR).Methods　We selected 106 diabetic patients who admitted to our hospital from June 2018 to June 2020 and divided into group A (proliferative DR), group B (non-proliferative DR), and group C (no retinopathy) according to the type of disease. The levels of serum CHIT1 and Irisin and the proportions of peripheral blood endothelial cells (CEC), endothelial progenitor cells (EPC) and circulating progenitor cells (CPC) were detected, and the differences of indexes among the groups were compared. The correlation between the expression of serum CHIT1 and Irisin and CEC, EPC and CPC was analyzed by Pearson correlation. Logistic regression analysis was used to analyze the risk factors for proliferative DR in diabetic patients.Results　The serum levels of CHIT1, Irisin and the proportion of CEC, EPC, CPC in peripheral blood cells were significantly different among the group A, group B and group C (all P<0.001). The serum levels of CHIT1 and the proportion of CEC in group A were significantly higher than those in group B and group C, while the levels of Irisin, the proportion of EPC and CPC in group A were significantly lower than those in group B and group C (all P<0.05). Pearson correlation analysis showed that the serum CHIT1 level was positively correlated with the ratio of CEC, but negatively correlated with EPC and CPC; the serum Irisin level was negatively correlated with the ratio of CEC but positively correlated with EPC and CPC (all P<0.001). The course of diabetes, serum CHIT1 and urinary microalbumin of patients with proliferative DR were significantly higher than those of patients with non-proliferative DR and no retinopathy, and the level of serum Irisin was significantly lower than that of patients with non-proliferative DR and no retinopathy (all P<0.05). Logistic regression analysis showed that duration of diabetes mellitus, CHIT1, Irisin and microalbuminuria were the influencing factors for DR in proliferative stage (all P<0.05).Conclusion　The abnormal expression of CHIT1 and Irisin occurs in the serum of patients with type DR, which is closely related to microvascular injury, and it is the influencing factor for the progression of DR patients to proliferative type.

参考文献/References:

［1］　ZHANG G H,CHEN H Y,CHEN W,ZHANG M Z.Prevalence and risk factors for diabetic retinopathy in China:a multi-hospital-based cross-sectional study［J］.Br J Ophthalmol,2017,101(12):310-316.
［2］　SIM-SERVAT O,HERNNDEZ C,SIM R.Diabetic retinopathy in the context of patients with diabetes［J］.Ophthalmic Res,2019,62(4):211-217.
［3］　VEYS K,ELMONEM M A,DYCK M V,JANSSEN M C,CORNELISSEN M A E,HOHENFELLNER K,et al.Chitotriosidase as a novel biomarker for therapeutic monitoring of nephropathic cystinosis［J］.J Am Soc Nephrol,2020,31(5):1092-1106.
［4］　WANG C,WANG L,LIU J,SONG J,SUN Y,LIN P,et al.Irisin modulates the association of interleukin-17A with the presence of non-proliferative diabetic retinopathy in patients with type 2 diabetes［J］.Endocrine,2016,53(2):459-464.
［5］　中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)［J］.中国实用内科杂志,2018,38(4):292-344.
Chinese Diabetes Society.Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition)［J］.Chin J Pract Int Med,2018,38(4):292-344.
［6］　中华医学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年)［J］.中华眼科杂志,2014,50(11):851-865.
Ophthalmology Group,Ophthalmology Society,Chinese Medical Association.Guidelines for clinical diagnosis and treatment of diabetic retinopathy in China (2014)［J］.Chin J Ophthalmol,2014,50(11):851-865.
［7］　TARBOUSH N A,ABU-YAGHI N E,AL EJEILAT L H,WAHED R K A,JERIS I N.Association of irisin circulating level with diabetic retinopathy:a case-control study［J］.Exp Clin Endocrinol Diabetes,2021,129(1):36-42.
［8］　STEINACKER P,FENEBERG E,HALBGEBAUER S,WITZEL S,VERDE F,OECKL P,et al.Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis:a multicenter study［J］.Amyotroph Lateral Scler Frontotemporal Degener,2021,22(3/4):276-286.
［9］　TORRES C,MATOS R,MORAIS S,CAMPOS M,LIMA M.Soluble endothelial cell molecules and circulating endothelial cells in patients with venous thromboembolism［J］.Blood Coagul Fibrinolysis,2017,28(8):589-595.
［10］　VUJOSEVIC S,ALDINGTON S J,SILVA P,HERNNDEZ C,SCANLON P,PETO T,et al.Screening for diabetic retinopathy:new perspectives and challenges［J］.Lancet Diabetes Endocrinol,2020,8(4):337-347.
［11］　SORRENTINO F S,MATTEINI S,BONIFAZZI C,SEBASTIANI A,PARMEGGIANI F.Diabetic retinopathy and endothelin system:microangiopathy versus endothelial dysfunction［J］.Eye (Lond),2018,32(7):1157-1163.
［12］　李娜,李宝新,张云良,张玛丽,李杰,田茜,等.不同类型糖尿病视网膜病变患者血清和肽素和几丁质酶1水平的变化及影响因素［J］.眼科新进展,2019,39(11):1044-1047,1051.
LI N,LI B X,ZHANG Y L,ZHANG M L,LI J,TIAN Q,et al.Changes in serum copeptin and chitotriosidase levels in patients with different types of diabetic retinopathy and its factors［J］.Rec Adv Ophthalmol,2019,39(11):1044-1047,1051.
［13］　MACIORKOWSKA M,MUSIAOWSKA D,MAYSZKO J.Adropin and irisin in arterial hypertension,diabetes mellitus and chronic kidney disease［J］.Adv Clin Exp Med,2019,28(11):1571-1575.
［14］　EL-LEBEDY D H,IBRAHIM A A,ASHMAWY I O.Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus［J］.Diabetes Metab Syndr,2018,12(1):643-648.
［15］　SONMEZ A,HAYMANA C,TAPAN S,SAFER U,CELEBI G,OZTURK O,et al.Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus［J］.Endocrine,2010,37(3):455-459.
［16］　姚杨,胡皓铭,张子扬,阳琰，王哲，罗丽娅，等.不同程度2型糖尿病合并视网膜病变患者血清25羟维生素D、鸢尾素水平比较及意义［J］.中国糖尿病杂志,2020,28(7):521-524.
YAO Y,HU H M,ZHANG Z Y,YANG Y,WANG Z,LUO L Y,et al.The comparison and significanse of serum 25 (OH) D and irisin levels in patients with different degrees of diabetic retinopathy［J］.Chin J Diabetes,2020,28(7):521-524.
［17］　HUANG L,YAN S,LUO L,YANG L Y.Irisin regulates the expression of BDNF and glycometabolism in diabetic rats［J］.Mol Med Rep,2019,19(2):1074-1082.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.
[11]李娜,李宝新,张云良,等.不同类型糖尿病视网膜病变患者血清和肽素和几丁质酶1水平的变化及影响因素[J].眼科新进展,2019,39(11):1044.[doi:10.13389/j.cnki.rao.2019.0239]
　LI Na,LI Bao-Xin,ZHANG Yun-Liang,et al.Changes in serum copeptin and chitotriosidase levels in patients with different types of diabetic retinopathy and its factors[J].Recent Advances in Ophthalmology,2019,39(7):1044.[doi:10.13389/j.cnki.rao.2019.0239]

备注/Memo

备注/Memo:
N/A
更新日期/Last Update: 2021-07-05